ACOR Forecast and Technical Stock AnalysisSell candidate since 2019-05-07 Loss -40.67%
Acorda Therapeutics gained 0.15% in the last trading day ( Friday, 19th Jul 2019 ), rising from $6.89 to $6.90 During day the stock fluctuated 2.49% from a day low at $6.83 to a day high of $7.00. The price has fallen in 6 of the last 10 days and is down by -6.25% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 57 764 more shares were traded than the day before. In total, 606 758 shares bought and sold for approximately $4.19 million.
- 30 day high of the ACOR stock price was $8.08 and low was $6.40.
- 90 day high was $12.15 and low was $6.40.
- 52 week high for the Acorda Therapeutics - $29.75 and low - $6.40.
Acorda Therapeutics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.44 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -43.68% during the next 3 months and, with 90% probability hold a price between $2.64 and $4.19 at the end of this period.
Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Acorda Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $7.51. On a fall, the stock will find some support from the short-term average at $6.82. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday July 17, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 31 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
Acorda Therapeutics finds support from accumulated volume at $6.88.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 2.49%. For the last week, the stock has had a daily average volatility of 4.12%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
4.12 %Average volatility
Very Low Low Medium High Very High
|ACOR $6.90 ($0.01 0.15%)|
ACOR is up $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACOR based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACOR analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now